{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14624", "batch_size": 260, "batch_pos": 207, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses factual language ('is too early to tell', 'will be able to manufacture') without high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_12592", "batch_size": 260, "batch_pos": 192, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "State of being and future possibility, not moderate verb + scale/impact.", "method": "llm_batch", "batch_id": "batch_3_18276", "batch_size": 260, "batch_pos": 178, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_4580", "batch_size": 260, "batch_pos": 174, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports a fact about manufacturing capacity but contains no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_16528", "batch_size": 260, "batch_pos": 174, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_18068", "batch_size": 260, "batch_pos": 163, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_7972", "batch_size": 260, "batch_pos": 155, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "The segment states uncertainty about doses, not capabilities or preparedness measures.", "method": "llm_batch", "batch_id": "batch_8_4680", "batch_size": 260, "batch_pos": 76, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment reports a quote about manufacturing capacity, not prices, economic data, or numerical metrics.", "method": "llm_batch", "batch_id": "batch_9_6148", "batch_size": 260, "batch_pos": 226, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment describes current uncertainty, not speculation about future relief.", "method": "llm_batch", "batch_id": "batch_10_17704", "batch_size": 260, "batch_pos": 145, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote is a neutral statement about manufacturing timeline.", "method": "llm_batch", "batch_id": "batch_11_12728", "batch_size": 260, "batch_pos": 142, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Reports statement about manufacturing capacity factually.", "method": "llm_batch", "batch_id": "batch_12_15208", "batch_size": 260, "batch_pos": 135, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
